Clinical Study of CD38\CS1 Chimeric Antigen Receptor T Cells in the Treatment of Refractory/Recurrent Multiple Myeloma
Clinical trial NCT06574958 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06574958
- Sponsor
- The Second Hospital of Shandong University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-30
- Primary completion
- 2025-01-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.